Profile

• September 2000-July 2006:  Medical Degree, Medical School, National and Kapodistrian University of Athens
• October 2008-December 2010: Training in Internal Medicine, District General Hospital of Mytilene "Vostaneio"
• January 2011-July 2012: Training in Cardiology, District General Hospital of Mytilene ‘Vostaneio’
• May 2013-May 2016: Training in Cardiology, University General Hospital, ATTIKON
• 2015: European Diploma in General Cardiology
• 2016: National Certificate of competence in Adult Transthoracic Echocardiography
• September 2016-April 2018: Sub-specialty training in Pacing and Electrophysiology, University General Hospital, ATTIKON (from 01/01/2017 until 31/12/2017, Grant from the Hellenic Society of Cardiology)
• 2017: European Association of Cardiovascular Imaging certification in Adult Transthoracic Echocardiography
• 2017: European Heart Rhythm Association Certification in Cardiac Device Specialist, Level 1
• May 2018-June 2021: Sub-specialty training in Pacing and Electrophysiology, Lancashire Cardiac Centre, Blackpool Victoria Hospital, United Kingdom

Postgragraduate Degree

• 2020-2021: MSc ‘Methodology of Biomedical Science, Biostatistics and Clinical Bioinfomatics’, University of Thessaly, Medical School, Biomath Lab
  

• February 2022- today: Cardiologist-Electrophysiologist, Deputy Director of Heart Rhythm Centre and Deputy Director of 3rd Cardiology Clinic at IASO General Clinic, under Dr. Panagiotis Ioannidis
• August 2021- January 2021: Consultant Cardiologist-Electrophysiologist in the 6th Cardiology Department of HYGEIA Hospital
• May 2018-June 2021: Fellow in Cardiology with a Specialist Interest in Electrophysiology, Lancashire Cardiac Centre, Blackpool Victoria Hospital, United Kingdom
• September 2016-April 2018: Clinical and Scientific Associate at the 2nd University Cardiology Department of University General Hospital ‘ATTIKON’
• May 2013-May 2016: Training in Cardiology, University General Hospital, ATTIKON
• August 2012-April 2013: General Practitioner at Mytilene Airport
• January 2011-July 2012: Training in Cardiology, District General Hospital of Mytilene ‘Vostaneio’
• October 2008-December 2010: Training in Internal Medicine, District General Hospital of Mytilene ‘Vostaneio’
• February 2008-September 2008: Research Fellow at the National and Kapodistrian University project ‘Study of the genetic substrate in patients with dilated cardiomyopathy’, in collaboration with the University of Cincinnati

• Dimitrios Katsaras is a Cardiologist with sub-specialty training in diagnosis and invasive treatment of arrhythmias. He has also experience in implantation and programming of Cardiac Implantable Electronic Devices (pacemakers, defibrillators).
• He has experience in all current 3D electroanatomical mapping systems used in invasive electrophysiology, but also in cryoballoon technology for the treatment of atrial fibrillation.
• He has been trained in the use of the innovative laser-balloon technology for the treatment of atrial fibrillation.

• Comparative safety and efficacy of paracetamol versus non-steroidal anti-inflammatory agents in neonates with patent ductus arteriosus: a systematic review and meta-analysis of randomized controlled trials
  Dimitrios N. Katsaras, Georgios N. Katsaras, Vasiliki I. Chatziravdeli, Garyfalia N.Papavasileiou, Maria Touloupaki, Georgios Mitsiakos, Chrysoula Doxani, Ioannis Stefanidis, Efthimios Dardiotis
  Br J Clin Pharmacol. 2022 Feb 24. Online ahead of print.
• A 59-Year-Old Woman with Familial Brugada Syndrome and the c.664C>T Variant of the Sodium Voltage-Gated Channel Alpha Subunit 5 (SCN5A) Gene, Accompanied by Congenital Absence of the Right Coronary Artery, Patent Foramen Ovale, and Ischemic Stroke
  Dimitrios Katsaras, Bangalore Thimmappa Sanjeev Kumar, Billal Patel, Shajil Chalil, Khalid Abozguia
  Am J Case Rep. 2021 Aug 27;22: e931535
• Intermittent Loss of Telemetry Data: Lessons from a Leadless Pacemaker
  Dimitrios Katsaras, Christopher Cassidy, Mohammed Lakha, Dawn Gordon, Grahame Goode, and Khalid Abozguia
  J Am Coll Cardiol Case Rep. 2021 Jan, 3 (1) 146–149
• An unusual response of pulmonary vein bigeminy to antral ablation
  Dimitrios Katsaras, MD, Jonathan Ariyaratnam, MRCP, Shajil Chalil, FRCP, Khalid Abozguia, PhD
  J Interv Card Electrophysiol. 2020 Jun 3
• COVID-19 Pandemic and Cardiac Electrophysiology: Guidance Protocol From a UK Tertiary Cardiac Centre
  Katsaras D, Chalil S, Abozguia K
  Crit Pathw Cardiol. 2020 Apr 24.
• Sphenopalatine ganglion block: an external gate to modulate cardiac autonomic tone and suppress premature ventricular beats?
  Katsaras DN,  Arvaniti CK,  Flevari PG,  Giannopoulos GV,  Batistaki CZ,  Stassinos VE,  Kostopanagiotou GG,  Deftereos SG, Iliodromitis EK,  Leftheriotis DI
  Ann Transl Med. 2018 Dec;6(23):457
• Differential multivariable risk prediction of appropriate shock versus competing mortality - A prospective cohort study to estimate benefits from ICD therapy.
  Leonard Bergau, Rik Willems, David J. Sprenkeler, Thomas H. Fischer, Panayota Flevari, Gerd Hasenfuß, Dimitrios Katsaras, Aleksandra Kirova, Stephan E. Lehnart, Lars Lüthje, Christian Röver, Joachim Seegers, Samuel Sossalla, Albert Dunnink, Rajevaa Sritharan, Anton E. Tuinenburg, Bert Vandenberk, Marc A. Vos, Sofieke C. Wijers, Tim Friede, Markus Zabel
  International Journal of Cardiology (Accepted 27 June 2018)
• Cryoballoon ablation under transesophageal echocardiographic guidance in dextrocardia.
  Leftheriotis D, Ikonomidis I, Flevari P, Frogoudaki A, Katsaras D.
  Hellenic J Cardiol. 2018 Apr 25
• Fluoxetine vs. placebo for the treatment of recurrent vasovagal syncope with anxiety sensitivity.
  Flevari P, Leftheriotis D, Repasos E, Katsaras D, Katsimardos A, Lekakis J.
  Europace. 2017 Jan;19(1):127-131
• Acute effects of unilateral temporary stellate ganglion block on human atrial electrophysiological properties and atrial fibrillation inducibility.
  Leftheriotis D, Flevari P, Kossyvakis C, Katsaras D, Batistaki C, Arvaniti C, Giannopoulos G, Deftereos S, Kostopanagiotou G, Lekakis J.
  Heart Rhythm. 2016 Nov;13(11):2111-2117
• Prevalence of heterozygous familial hypercholesterolaemia and its impact on long-term prognosis in patients with very early ST-segment elevation myocardial infarction in the era of statins.
  Rallidis LS, Triantafyllis AS, Tsirebolos G, Katsaras D, Rallidi M, Moutsatsou P, Lekakis J.Atherosclerosis. 2016 Jun; 249:17-21
• Self-assessment of health status is associated with inflammatory activation and predicts long-term outcomes in chronic heart failure.
  Parissis JT, Nikolaou M, Farmakis D, Paraskevaidis IA, Bistola V, Venetsanou K, Katsaras D, Filippatos G, Kremastinos DT.
  Eur J Heart Fail. 2009 Feb;11(2):163-9

• Member of the Hellenic Society of Cardiology since 2016
• Member of the Echocardiography Working Group of the Hellenic Society of Cardiology since 2022
• Member of the Pacing and Electrophysiology Working Group of the Hellenic Society of Cardiology since 2022
• Member of the European Society of Cardiology since 2016
• Member of the European Heart Rhythm Association since 2017
• Member of the British Heart Rhythm Society since 2018
• Member of the Hellenic Society of Cardiopulmonary Resuscitation

• Participation as a sub-investigator in the multicentre randomized clinical trials Συμμετοχή: EMPHASIS-HF (ClinicalTrials.gov Identifier: NCT00232180), FAIR-HF (ClinicalTrials.gov Identifier: NCT00520780), REACH-UP (ClinicalTrials.gov Identifier: NCT00443690), EU-CERT-ICD and at the single-centre observational study ‘Validation of a smartphone-based recorder for detection of cardiac arrhythmias’ (ClinicalTrials.gov Identifier: NCT03996954)
• Participation in smaller single-centre studies
• February 2008-September 2008: Research Fellow at the National and Kapodistrian University project ‘Study of the genetic substrate in patients with dilated cardiomyopathy’, in collaboration with the University of Cincinnati